Anti‐EGFR antibody‐drug conjugate for triple‐negative breast cancer therapy.
- Published in:
- Engineering in Life Sciences, 2021, v. 21, n. 1, p. 37, doi. 10.1002/elsc.202000027
- By:
- Publication type:
- Article
Works matching IS 16180240 AND DT 2021 AND VI 21 AND IP 1
Results: 6
1
2
Issue Information.
- Published in:
- Engineering in Life Sciences, 2021, v. 21, n. 1, p. 2, doi. 10.1002/elsc.202170012
- Publication type:
- Article
3
Cover Picture: Engineering in Life Sciences 1–2'21.
- Published in:
- Engineering in Life Sciences, 2021, v. 21, n. 1, p. NA, doi. 10.1002/elsc.202170011
- Publication type:
- Article
4
Diffusion profiles in L. lactis biofilms under different conditions.
- Published in:
- Engineering in Life Sciences, 2021, v. 21, n. 1, p. 29, doi. 10.1002/elsc.202000059
- By:
- Publication type:
- Article
5
Online monitoring applying the anaerobic respiratory monitoring system reveals iron(II) limitation in YTF medium for Clostridium ljungdahlii.
- Published in:
- Engineering in Life Sciences, 2021, v. 21, n. 1, p. 19, doi. 10.1002/elsc.202000054
- By:
- Publication type:
- Article
6
A novel LysR‐type regulator negatively affects biosynthesis of the immunosuppressant brasilicardin.
- Published in:
- Engineering in Life Sciences, 2021, v. 21, n. 1, p. 4, doi. 10.1002/elsc.202000038
- By:
- Publication type:
- Article